Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Phathom Pharmaceuticals (Nasdaq: PHAT) will participate in two investor conferences in New York in September 2026: the Cantor Global Healthcare Conference on September 9, 2026 with a fireside chat at 10:55 a.m. EDT, and the H.C. Wainwright 28th Annual Global Investment Conference on September 15, 2026 with a fireside chat at 3:30 p.m. EDT. Management will also hold one-on-one meetings at both events. Webcasts and archived recordings will be available for 90 days via the News & Events section of Phathom’s investor website.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

FLORHAM PARK, N.J., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on commercializing and developing novel treatments for gastrointestinal (GI) diseases, announced today that members of its management team are scheduled to participate in the following upcoming investor conferences in September:

2026 Cantor Global Healthcare Conference in New York, NY
Date: Wednesday, September 9, 2026
Fireside Chat: 10:55 am EDT
Management to participate in one-on-one meetings throughout the conference

H.C. Wainwright 28th Annual Global Investment Conference in New York, NY
Date: Tuesday, September 15, 2026
Fireside Chat: 3:30 pm EDT
Management to participate in one-on-one meetings throughout the conference

To access the live webcast and archived recordings of each event, visit the News & Events section of the Phathom website at https://investors.phathompharma.com/news-events/events-and-presentations. Recordings will be available for 90 days following the conclusion of each meeting.

About Phathom Pharmaceuticals, Inc.
Phathom Pharmaceuticals is a biopharmaceutical company focused on the commercialization and development of novel treatments for gastrointestinal diseases. Phathom has in-licensed the exclusive rights to vonoprazan, a first-in-class potassium-competitive acid blocker (PCAB) for the U.S., Europe and Canada. Phathom currently markets vonoprazan in the United States as VOQUEZNA^® (vonoprazan) tablets for the relief of heartburn associated with Non-Erosive GERD in adults, the healing and maintenance of healing of Erosive GERD in adults and relief of associated heartburn, and as part of VOQUEZNA^® DUAL PAK^® (vonoprazan tablets, amoxicillin capsules) and VOQUEZNA^® TRIPLE PAK^® (vonoprazan tablets, amoxicillin capsules, clarithromycin tablets) for the treatment of H. pylori infection in adults. For more information about Phathom, visit the company’s website at www.phathompharma.com and follow on LinkedIn and X.

MEDIA CONTACT
Nick Benedetto
1-877-742-8466
media@phathompharma.com

INVESTOR CONTACT
Eric Sciorilli
1-877-742-8466
ir@phathompharma.com

© 2026 Phathom Pharmaceuticals. All rights reserved. VOQUEZNA, VOQUEZNA DUAL PAK, VOQUEZNA TRIPLE PAK, Phathom Pharmaceuticals, and their respective logos are registered trademarks of Phathom Pharmaceuticals, Inc.

FAQ

When will Phathom Pharmaceuticals (PHAT) present at the 2026 Cantor Global Healthcare Conference?

Phathom will present at the 2026 Cantor Global Healthcare Conference on September 9, 2026. According to Phathom, its fireside chat is scheduled for 10:55 a.m. EDT, with management also participating in one-on-one investor meetings during the conference.

What time is Phathom Pharmaceuticals’ (PHAT) fireside chat at the 2026 H.C. Wainwright Global Investment Conference?

Phathom’s fireside chat at the H.C. Wainwright 28th Annual Global Investment Conference is at 3:30 p.m. EDT on September 15, 2026. According to Phathom, its management team will also attend one-on-one meetings with investors throughout the event.

How can investors access the Phathom Pharmaceuticals (PHAT) conference webcasts in September 2026?

Investors can access Phathom’s live and archived conference webcasts via the News & Events section of its investor website. According to Phathom, recordings for each September 2026 event will remain available online for 90 days after each meeting concludes.

Will Phathom Pharmaceuticals (PHAT) hold one-on-one investor meetings at the September 2026 conferences?

Yes, Phathom’s management plans to participate in one-on-one investor meetings at both September 2026 conferences. According to Phathom, these meetings will occur throughout the Cantor Global Healthcare Conference and the H.C. Wainwright 28th Annual Global Investment Conference.

Where are the September 2026 investor conferences featuring Phathom Pharmaceuticals (PHAT) being held?

Both September 2026 conferences featuring Phathom are being held in New York, NY. According to Phathom, the company will appear at the Cantor Global Healthcare Conference and the H.C. Wainwright 28th Annual Global Investment Conference, each including a scheduled fireside chat.